SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Sep-23 4:29 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 11-Sep-23 | Option Exercise | 18,000 | $7.49 | $134,820.00 | 100% 0 to 18.0K | |
13-Sep-23 4:29 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 11-Sep-23 | Option Sale | 18,000 | $10.50 | $189,050.00 | (100%) 18.0K to 0 | |
03-Nov-20 7:56 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 30-Oct-20 | Market Purchase | 115,686 | $17.24 | $1,994,070.00 | 11% 1.02M to 1.14M | 2% |
30-Jul-19 7:37 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 29-Jul-19 | Market Purchase | 29,867 | $17.13 | $511,702.00 | 3% 1.12M to 1.15M | 2% |
30-Jul-19 7:37 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 26-Jul-19 | Market Purchase | 26,500 | $16.83 | $446,035.00 | 2% 1.09M to 1.12M | 4% |
19-Jul-19 6:38 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 19-Jul-19 | Market Purchase | 60,000 | $17.81 | $1,068,580.00 | 4% 1.36M to 1.42M | (2%) |
19-Jul-19 6:38 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Jul-19 | Market Purchase | 1,280 | $16.96 | $21,715.00 | < 1% 1.36M to 1.36M | 3% |
12-Sep-18 7:11 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 10-Sep-18 | Market Purchase | 1,058,820 | $17.00 | $18,000,000.00 | 353% 300.33K to 1.36M | 3% |
15-Mar-18 6:20 PM View: | Biohaven Pharmaceutical Hol... (BHVN) | 14-Mar-18 | Grant | 72,727 | $27.50 | $1,999,990.00 | 4% 1.98M to 2.05M | 65% |
29-Jan-18 4:14 PM View: | Vyne Therapeutics Inc. (VYNE) | 29-Jan-18 | Conversion | 3,717,120 | -- | -- | 1264% 294.12K to 4.01M | |
29-Jan-18 4:14 PM View: | Vyne Therapeutics Inc. (VYNE) | 25-Jan-18 | Purchase | 294,118 | $17.00 | $5,000,010.00 | 100% 0 to 294.12K | |
09-May-17 4:45 PM View: | Biohaven Pharmaceutical Hol... (BHVN) | 09-May-17 | Conversion | 1,506,820 | -- | -- | 100% 1.51M to 3.01M | |
09-May-17 4:45 PM View: | Biohaven Pharmaceutical Hol... (BHVN) | 09-May-17 | Purchase | 470,000 | $17.00 | $7,990,000.00 | 16% 3.01M to 3.48M | |
13-Oct-15 1:30 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 13-Oct-15 | Conversion Duplicate | 3,433,650 | -- | -- | 1132% 303.2K to 3.74M | |
13-Oct-15 1:30 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 13-Oct-15 | Private Purchase Duplicate | 454,545 | $11.00 | $5,000,000.00 | 12% 3.74M to 4.19M | |
09-Oct-15 4:03 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 07-Oct-15 | Purchase | 13,352 | $11.00 | $146,872.00 | 5% 289.85K to 303.21K | |
21-Jul-15 6:59 PM View: | Sierra Oncology, Inc. (SRRA) | 21-Jul-15 | Conversion | 2,109,300 | -- | -- | 87% 2.43M to 4.54M | |
21-Jul-15 6:59 PM View: | Sierra Oncology, Inc. (SRRA) | 21-Jul-15 | Acquisition (other) | 108,971 | $5.22 | $568,284.00 | 2% 4.54M to 4.65M | |
21-Jul-15 6:59 PM View: | Sierra Oncology, Inc. (SRRA) | 21-Jul-15 | Purchase | 220,000 | $17.00 | $3,740,000.00 | 5% 4.65M to 4.87M | |
14-Apr-15 5:22 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 14-Apr-15 | Conversion Duplicate | 3,192,060 | -- | -- | 76% 4.2M to 7.39M | |
14-Apr-15 5:22 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 14-Apr-15 | Purchase Duplicate | 1,012,500 | $5.00 | $5,062,500.00 | 14% 7.39M to 8.4M | |
14-Feb-08 9:42 PM View: | Biodel Inc. (ALBO) | 12-Feb-08 | Market Sale | 132,000 | $15.50 | $2,046,000.00 | (8%) 1.69M to 1.55M | 99% |
14-Nov-07 9:29 PM View: | BioForm Medical, Inc. (BFRM) | 09-Nov-07 | Conversion | 5,394 | -- | -- | 10% 56.0K to 61.39K | |
14-Nov-07 9:29 PM View: | BioForm Medical, Inc. (BFRM) | 09-Nov-07 | Conversion | 1,846,150 | -- | -- | 3007% 61.39K to 1.91M | |
18-May-07 4:19 PM View: | Biodel Inc. (ALBO) | 16-May-07 | Conversion | 1,078,930 | -- | -- | 178% 607.02K to 1.69M |